Current Challenges in Hematology

 

Current Challenges in Hematology
E

Patient Journey for a Transplant-Eligible Patient From 1L to Subsequent Lines in MM

By Current Challenges in Hematology FEATURING Elena Zamagni
By Current Challenges in Hematology FEATURING Elena Zamagni
0 views
February 6, 2023
Comments 0
Login to view comments. Click here to Login
1st Edition
17:23
Current Challenges in Hematology

2023 Updates on Sequencing in CLL

Feat. L. Scarfò
13:44
Current Challenges in Hematology

Current Updates in High-Risk AML

Feat. A. Isidori
17:35
Current Challenges in Hematology

MRD in AML: How Does it Guide Our Treatment Choices?

Feat. A. Venditti
18:43
Current Challenges in Hematology

Emerging Targeted Therapies and Combinations in AML

Feat. A. de la Fuente
07:10
Current Challenges in Hematology

IDH1-Mutated AML Patient Case

Feat. A. de la Fuente
16:56
Current Challenges in Hematology

Targeting Inflammation in LR-MDS

Feat. A. Sophie Kubasch
16:39
Current Challenges in Hematology

LR-MDS 2023: Standards and Perspectives

Feat. U. Platzbecker
15:49
Current Challenges in Hematology

AML in 2023: How Do Cancer Genomics Guide Therapeutic Choices?

Feat. M. Teresa Voso
16:57
Current Challenges in Hematology

How I Treat CML in Advanced Phases

Feat. G. Saglio
30:15
Current Challenges in Hematology

What's New Beyond 1L Treatment in CML: Ponatinib

Feat. G. Rosti
22:15
Current Challenges in Hematology

Efficacy of BCMA-Targeted Therapies in Pretreated Patients With R/R …

Feat. C. Cerchione
17:32
Current Challenges in Hematology

Patient Journey for a Transplant-Ineligible Patient With MM From 1L …

Feat. R. Mina
31:28
Current Challenges in Hematology

Current Treatment Strategies in MM: Overcoming Incurability

Feat. M. Mateos
20:59
Current Challenges in Hematology

Patient Journey for a Transplant-Eligible Patient From 1L to Subsequ…

Feat. E. Zamagni
18:48
Current Challenges in Hematology

Venetoclax-Based Combinations in Newly Diagnosed AML: A New Golden S…

Feat. C. DiNardo
12:27
Current Challenges in Hematology

What's New Beyond 1L Treatment in CML: Asciminib

Feat. M. Breccia